Technical Analysis for GALT - Galectin Therapeutics Inc.

Grade Last Price % Change Price Change
C 2.82 2.18% 0.06
GALT closed up 2.18 percent on Wednesday, November 20, 2024, on approximately normal volume. It was able to find support at its 50 day moving average.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Down

Date Alert Name Type % Chg
20 DMA Support Bullish 0.00%
50 DMA Support Bullish 0.00%
Outside Day Range Expansion 0.00%
20 DMA Support Bullish 2.18%
50 DMA Support Bullish 2.18%
Non-ADX 1,2,3,4 Bullish Bullish Swing Setup 2.18%
NR7 Range Contraction 2.18%
Inside Day Range Contraction 2.18%
20 DMA Support Bullish 4.65%
50 DMA Support Bullish 4.65%

   Recent Intraday Alerts

Alert Time
Possible NR7 1 day ago
Possible Inside Day 1 day ago
20 DMA Support 2 days ago
50 DMA Support 2 days ago
Up 3% 2 days ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Galectin Therapeutics Inc., a development stage company, engages in the development of therapies for cancer and fibrotic disease. Its lead product candidates include GR-MD-02, a complex polysaccharide polymer for the treatment of liver fibrosis and fatty liver disease for which the company intends to initiate a Phase I clinical trial in patients with non-alcoholic steatohepatitis; and GM-CT-01, a linear polysaccharide polymer comprising mannose and galactose that is in a Phase I/II clinical trial in Europe as a combination therapy with a tumor vaccine in patients with advanced melanoma. The company was formerly known as Pro-Pharmaceuticals, Inc. and changed its name to Galectin Therapeutics Inc. in May 2011. Galectin Therapeutics Inc. was founded in 2000 and is based in Norcross, Georgia.
Classification

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Keywords: Cancer Alcohol Tumor Melanoma Hepatitis Steatohepatitis Non Alcoholic Fatty Liver Disease Liver Disease Therapies For Cancer Fibrotic Disease Lectins Liver Fibrosis Galectin Lactose Combination Therapy Fatty Liver Fatty Liver Disease Galectin 3 Galecto Biotech

Is GALT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 4.2684
52 Week Low 1.555
Average Volume 138,218
200-Day Moving Average 2.60
50-Day Moving Average 2.69
20-Day Moving Average 2.69
10-Day Moving Average 2.84
Average True Range 0.16
RSI (14) 55.36
ADX 28.68
+DI 20.52
-DI 12.90
Chandelier Exit (Long, 3 ATRs) 2.68
Chandelier Exit (Short, 3 ATRs) 2.94
Upper Bollinger Bands 3.04
Lower Bollinger Band 2.35
Percent B (%b) 0.68
BandWidth 25.29
MACD Line 0.05
MACD Signal Line 0.05
MACD Histogram 0.0024
Fundamentals Value
Market Cap 174.1 Million
Num Shares 61.8 Million
EPS -0.76
Price-to-Earnings (P/E) Ratio -3.70
Price-to-Sales 0.00
Price-to-Book 207.70
PEG Ratio 0.00
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 3.04
Resistance 3 (R3) 3.02 2.92 3.00
Resistance 2 (R2) 2.92 2.86 2.93 2.99
Resistance 1 (R1) 2.87 2.83 2.89 2.89 2.98
Pivot Point 2.77 2.77 2.78 2.78 2.77
Support 1 (S1) 2.72 2.71 2.74 2.74 2.65
Support 2 (S2) 2.62 2.68 2.63 2.64
Support 3 (S3) 2.57 2.62 2.63
Support 4 (S4) 2.59